|Articles|September 16, 2009
- Fall 2009
- Volume 8
- Issue 3
CYP2D6 Inhibitors
Advertisement
>
Strong CYP2D6 Inhibitors* Paxil (paroxetine)
>
Prozac (fluoxetine)
>
Wellbutrin (bupropion)
>
Moderate CYP2D6 Inhibitors Cymbalta (duloxetine)
>
Zoloft (sertraline)
>
Weak CYP2D6 Inhibitors Celexa (citalopram)
>
Effexor (venlafaxine)
>
Lexapro (escitalopram)
Source: Abbreviated listing from Handbook of Essential Psychopharmacology, second edition, 2005
*To be avoided with tamoxifen
Articles in this issue
over 16 years ago
Web Exclusive: When is Multidisciplinary Care Really Needed?over 16 years ago
The Internal Flameover 16 years ago
Message from the Editorover 16 years ago
Letters from Our Readersover 16 years ago
Overheatedover 16 years ago
I Laughedover 16 years ago
Kidney Cancer & Lung Cancerover 16 years ago
Cancer Screeningover 16 years ago
Life Preserver?Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Reading the Fine Print: Why Ingredient Awareness Matters After Cancer
2
Breaking Down Metastatic Triple-Negative Breast Cancer Treatments
3
Early Data Show INCA033989 Activity in Calreticulin-Driven Myelofibrosis
4
Gedatolisib Plus Faslodex Shows Efficacy in Advanced HR+ Breast Cancer
5